The Miami Entrepreneur

: EyePoint Pharmaceuticals’ stock soars 212% after company announces positive data for macular degeneration treatment

Read Time:5 Second

EyePoint’s stock is on track for its biggest ever one-day percentage gain in heavy volume.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Economic Report: U.S. factory orders drop 3.6% in October on weak transportation orders
Next post Top crypto picks to buy at rising market before it’s too late